Background: Lipid metabolism has an important role in fetal development during the late stage of gestation, including growth and fat accretion in utero, increasing amniotic fluid lecithin levels with maturation of pulmonary function and changes in the levels of minor phospholipids in amniotic fluid.
Introduction
Cholesterol was found to represent over 50% of the neutral lipid of both the total surfactant and the lamellar body fractions, and de novo synthesis of cholesterol from [1- 14 C]acetate accounted for only 1% of the surfactant cholesterol, the remainder being derived from exogenous cholesterol supplied as serum lipoproteins. 1 The function of cholesterol in surfactant has not been established; however, it is believed to facilitate spreading of dipalmitoylphosphatidylcholine at the air-liquid interface in the lung, lowering surface tension.
1,2 Hass et al. 3 suggested that lung cholesterol metabolism might be subject to regulation by both low-density lipoprotein (LDL) and high-density lipoprotein (HDL). The infants who subsequently developed respiratory distress had significantly lower lipoprotein levels than the levels in normal newborns and in preterm infants without respiratory distress after delivery. 4, 5 Additionally several factors significantly affected cord serum levels, especially gestational age and birth weight. 4, 5 Lipid metabolism has an important role in fetal development during the late stage of gestation, including growth and fat accretion in utero, transport of cholesterol to the fetal adrenal for hormone synthesis, increasing amniotic fluid lecithin levels with maturation of pulmonary function and changes in the levels of minor phospholipids in amniotic fluid. 6 A deficiency or reduced transport of essential and/or long-chain polyunsaturated fatty acids, which resulted in lipid alterations could inhibit normal fetal growth and maturation, one effect of which would be delayed development of the fetal lungs, which could lead to the respiratory distress syndrome (RDS) post-natally.
Normal fetal growth is a positive function of gestational weight gain, modified by maternal prepregnancy body body mass index (BMI). 7 Both maternal prepregnancy weight and weight gain during gestation are important factors affecting fetal growth and birth weight. 8 The purpose of this study was to evaluate maternal and cord lipid profile in preterm infants with RDS compared to a control group without RDS.
Materials and methods
From 1 January to 1 December, 2005, a total of 1649 neonates were admitted to the neonatal intensive care unit. The inclusion criterion at admission was preterm infant whose gestational age is between 25 and 36 weeks. The exclusion criterion at admission were: being mature, a >36 weeks gestational age, small for gestational age, large for gestational age, asphyxiated at birth and major congenital anomalies. Mothers whose pregnancies were complicated by hypertension and pre-eclampsia, or with maternal history of endocrine disorders such as diabetes, hypercholesterolaemia, thyroid or adrenal problems, or who had received alcohol were excluded. Infant whose mother was taking drugs affecting the lipid metabolites such as steroid (except for fetal lung maturation) and ritodrine were excluded from the study. We aimed to minimize the effect of the intrauterine environment on lipid profile. Four hundred and eighty-five infants in the gestational age of interest were admitted. Of these, 251 infants were ineligible for the following reasons; small for gestational age (87 infants), large for gestational age (35 infants), asphyxiated at birth (47 infants), associated with major congenital anomalies (12 infants), with maternal history of endocrine disorders (35 infants), whose mothers smoked (15 infants), mothers whose pregnancies were complicated by hypertension (47 infants) and who had received the listed drugs (19 infants). Forty-six infants had more than one reason. Of 234 eligible infants, in 68 infants the parents declined consent. So, 166 infants with their mothers were included in the study. Informed consent was obtained from the parents before enrollment and the project was approved by Erciyes University Hospital Committee for Research on Human Subjects. The presence of antenatal corticosteroid administration, gender, gestational age, birth weight, height, ponderal index, length, mode delivery, Apgar scores and mode of delivery were recorded for each infant. Their mothers were analyzed for maternal age, maternal membrane ruptured >24 h, parity, prepregnant weight, height and BMI. Ponderal index (birth weight/length 3 ) for babies was birth weight divided by height cubed. Pregravid BMI was calculated as weight (kg) divided by height square (m 2 ) for each mother. The study population consisted of pregnant women with known menstrual dates who registered with participating obstetricians before 17 weeks of gestation at Gevher Nesibe Hospital. The infant's gestational age at birth was calculated from the date of the last menstrual period and confirmed by ultrasonography. After an infant met admission criteria, the diagnosis of RDS was established by meeting all of the following criteria: physical examination notable for chest wall retractions and cyanosis on room air, compatible X-ray demonstrating diffuse alveolar atelectasis, arterial blood gas documentation of metabolic acidosis, hypoxaemia and hypercapnia. Control infants met all admission requirements but did not develop respiratory distress. Cord blood samples were obtained from umbilical vein, immediately after delivery and allowed to clot at room temperature for 20 min. Serum was separated by centrifugation (20 min, 2500 r.p.m.) and kept at À201C until the analysis within a maximum of 15 days. Blood was taken from peripheral veins of the mothers after an overnight fast of at least 10 h within 48 h after the delivery. Serum triglyceride, total and HDL cholesterol concentrations were measured using standard enzymatic methods with a fully automated analyzer (Konelab, Espoo, Finland). Very low-density lipoprotein (VLDL) and LDL cholesterol concentrations were calculated (LDL ¼ total cholesterol HDL triglyceride/5 (VLDL cholesterol)). 9 The difference between the groups was evaluated by Samples t and Mann-Whitney U-tests, where appropriate. The w 2 tests were used to indicate within-group changes in proportions. In all tests, P-value <0.05 was accepted as significant. Univariate associations between the study variables were analyzed by calculating Pearson's correlation coefficients. Stepwise linear regression analyses were performed to determine the independent contributions of total cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol and triglyceride of infants to their characteristics and mothers' variables. All the parameters with P<0.1 on univariate analysis were entered into the models. Data were analyzed by using SPSS v10.0 programme.
Results
The study groups consisted of 166 preterm infants with gestational ages ranging from 25 to 36 weeks, and birth weights ranging from 748 to 2495 g. Of these infants, 57 developed RDS and 109 infants served as controls. All the parameters were evaluated for the effects of gestational age by dividing the patient population into four gestational age groups (group 1:34 to 36 weeks, group 2:31 to 33 weeks, group 3:28 to 30 weeks; group 4:25 to 27 weeks). All infants with gestational age of 25 to 27 weeks were confirmed as having RDS, so no control non-RDS group was available ( Table 1) . Characteristics of the infants and their mothers were not significantly different between the infants with RDS and non-RDS for all the gestational age groups (Tables 1 and 2 , P>0.05).
Mean total, HDL and LDL cholesterol levels were significantly lower in all gestational age groups of the infants with RDS and their mothers than in the controls (P<0.05), and serum VLDL cholesterol and triglyceride levels were similar to each other (P>0.05, Table 3 and 4). The differences in serum VLDL cholesterol and triglyceride levels of both infants and their mothers were found to be significant when combined data for all preterm infants with RDS were compared to combined data for all preterm infants without RDS (P<0.05). Each parameter of the mothers' lipid profile, gestational age, weight gain during pregnancy and ponderal index were positively correlated with the lipid profile of the infants when combined data for all preterm infants with and without RDS (P<0.05).
Pregravid BMI was positively correlated with mothers' and infants' total and LDL cholesterol levels (P<0.05), and it was also positively correlated with the maternal HDL cholesterol levels (P<0.05). Gestational age was positively correlated with total, HDL, LDL and VLDL cholesterols and triglycerides levels of the mothers (r ¼ 0.627, 0.487, 0.564, 0.589 and 0.475, respectively, P<0.05).
Likewise, it was positively correlated with the lipid profile of infants (P<0.05). The lipid profiles of both infants and their mothers were not related to the maternal age, antenatal steroids using, maternal membrane rupture longer than 24 h, gender and parity (P>0.05). In stepwise linear regression models, for the triglyceride level of infant, significant associations included the pregravid BMI (t ¼ 1.989, b ¼ 0.134, P<0.05), and for the LDL cholesterol levels of infant, significant association included weight gain during pregnancy (t ¼ 1.995, b ¼ 0.136, P<0.05). For the HDL cholesterol, VLDL cholesterol and total cholesterol levels of infants, there is no significant association (P>0.05).
Discussion
Factors during pregnancy and delivery, as well as certain diseases, can influence fetal and neonatal lipid metabolism. 6, 10, 11 In agreement with our findings, Lane et al. 5 found that preterm infants developing respiratory distress post-natally had significantly lower cord serum lipid levels than those of normal term infants or preterm infants free of respiratory distress. Significantly lower cord serum lipid levels are evidence of reduced essential fatty acids and long-chain polyunsaturated fatty acid supply, which could inhibit fetal growth in utero, delaying maturation of fetal lungs. Wojcicka-Jagodzinska et al.
12 speculated that a reduction in the cholesterol concentrations of amniotic fluid of hypertensive 9 (8-9) 9 (6-10) 9 (7-10) F Control 9 (7-9) 9 (8-9) 9 (6-10)
Abbreviation: RDS, respiratory distress syndrome.
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Maternal and cord serum lipids in RDS T Gunes et al mothers in whose children the respiratory distress syndrome developed, might have a prognostic significance in the prediction of respiratory distress in early neonatal period. Compared with the values of non-RDS infants, lower levels of cholesterol and HDL cholesterol found in infants with RDS indicated a limited ability to metabolize VLDL, probably related to lipoprotein lipase impairment. Gestational age was positively correlated with the maternal serum lipid levels in our study, and it was consistent with the work of Sattar et al. 13 However, no statistically significant differences in the level of lipids, lipoproteins and apolipoproteins in cord blood serum of the studied newborns depending on their gestational age were confirmed in the study of Pac-Kozuchowska. 14 Reduced levels of serum HDL cholesterol found in infants with RDS and in their mothers suggest that it may have an important role on regulating surfactant synthesis. Voyno Yasenetskaya et al. 15 demonstrated that both LDL and HDL cholesterols stimulate primary cultures of type II cells to secrete phosphatidylcholine, the major phospholipid component of pulmonary surfactant. Maternal lipid profile was related to those of their infants on univariate analysis in our study. Our findings are in contrast with Lane et al., 6 who suggested that the changes in the cord serum lipids and apolipoproteins in the RDS and non-RDS infant groups indicated that placental transport of lipid components might be abnormal in preterm infants who developed RDS. It might be due to the fact that maternal lipid profile and characteristics determined in our study were not evaluated in their study. Additionally, we found that weight gain during pregnancy was related to LDL cholesterol levels of infants, and pregravid BMI was related to triglyceride levels of the infants in stepwise linear regression analysis. Fetal metabolism, and consequently fetal growth, directly depends on the nutrients crossing the placenta, and therefore the mother adapts her metabolism to support this continuous draining of substrates. These results suggest that lower lipid parameters in RDS infants are evidences of reduced maternal supply, which could delay lung maturation. Pregravid BMI and weight gain during pregnancy were related to both maternal and infants' lipid profile in our study. The necessity of adequate gestational weight gain for optimal pregnancy outcome is recognized; however, the specific components of gestational weight gain that are critical for fetal growth and development are not delineated clearly. Normal fetal growth is a positive function of gestational weight gain, modified by maternal prepregnancy body BMI. To optimize birth weight, the Institute of Medicine guidelines for gestational weight gain recommend the highest gestational weight gain for underweight women, intermediate gestational weight gain for normal weight women and lowest gestational weight gain for obese women. 7 High BMI and environmental factors such as weight gain, dietary and alcohol habits may influence lipid metabolism during pregnancy. 16, 17 Appropriate maternal weight gain during pregnancy has been shown to decrease morbidity in neonatal period. The results of Muscati et al. 18 emphasized the importance of the timing of gestational weight gain and showed an advantage in deferring a larger portion of required weight gain to late pregnancy, to promote fetal growth while reducing the risk of high weight retention and its potential adverse health consequences. Butte et al. 19 suggested that appropriate, but not excessive, gestational weight gain is needed to optimize infant birth weight and minimize maternal postpartum fat retention. So, appropriate weight gain during pregnancy is related to the neonatal outcome. Catalano et al. 20 investigated the factors (maternal height, weight, pregravid weight, weight gain, education and parity, paternal height and weight, neonatal sex and gestational age) affecting fetal growth with birth weight and body composition and concluded that various genetic and environmental factors may modify fetal growth by differentially affecting the growth of fetal fat and fat-free mass. Our findings suggest that pregravid BMI and weight gain during pregnancy affect the lipid profile of infants and their mothers. Consequently, these maternal characteristics might have a prognostic significance in the prediction of respiratory distress in early neonatal period. On the other hand, the reason for lower lipid levels in infants and their mothers of RDS groups needs to be explained. Our study has its limitation that the dietary intakes of the mothers during pregnancy were not evaluated. Dietary deviations in maternal fatty acids intake throughout pregnancy may affect the nature of fatty acids crossing the placenta, having consequences to post-natal development. 21 In conclusion, RDS is accompanied with lipid alteration in the infants and their mothers. We suggest that cord and maternal serum lipid levels might be with the potential to detect those infants at risk for RDS that develops post-natally. Additionally, pregravid BMI and weight gain during pregnancy might have a prognostic significance in the prediction of respiratory distress in early neonatal period. Maternal and cord serum lipids in RDS T Gunes et al
